Compliance Blog
Pharmaceutical & Medical Device Compliance Congress Turns 20
It is hard to believe that this is the 20th Anniversary of the Pharma Compliance Congress. Since the Pharmaceutical Compliance Forum (“PCF”) sponsored the first Congress in 2000, the profession has...
read moreLatest Issue of the Policy & Medicine Compliance Update
For August, our focus is once again on compliance in research, and we start with a look at the world of collaborative research. Maureen Lloyd and her fellow co-authors take an in-depth look at the...
read moreThe Time for Effective Compliance Is NOW
Recently, the Justice Department targeted three companies in the pharmaceutical and medical device industry (Rochester Drug Co-Operative, Indivior, and Life Spine) as it aims to stamp out health...
read moreMitchell Hamline Team Takes 2nd Place in Annual Health Law Regulatory and Compliance Competition
I am thrilled to share some great news! The 8th Annual Health Law Regulatory and Compliance Competition was held this past weekend at The University of Maryland Francis King Carey School of Law....
read moreDecember 2018 Issue Now Available
Given that this is our last issue of 2018, we decided to focus on several important topics that never seem to get enough airtime. Therefore, we are featuring articles on privacy, including the...
read moreSeason’s Greetings from Whitelaw Compliance Group
Click to view larger version
read moreWhitelaw Compliance Group Presents at the 19th Annual Pharmaceutical & Medical Device Conference
On Thursday, November 8th, Dr. Seth Whitelaw will be joining a distinguished panel of experts for an interactive discussion on the evolution of the compliance office from “Compliance 1.0 to 3.0”. ...
read moreOpen Payments 2.0 – Big Changes Are Forecast
The forecast for transparency just turned cloudy. Key Messages Tucked into the latest opioid law are changes to the Sunshine Act.Beginning in 2022, drug and device companies now must report...
read moreDrug Pricing—The Next Compliance Waterloo
My latest article co-authored with Nicodemo Fiorentino and Jennifer O'Leary is available as a free download from the Mitchell Hamline Law Review. The current drug pricing war pits the...
read more